US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 1.4100
- +0.3200+29.36%
Close Nov 29 13:00 ET
- 1.4099
- -0.0001-0.01%
Post 17:01 ET
12.33MMarket Cap-693P/E (TTM)
1.5000High1.1600Low854.28KVolume1.1600Open1.0900Pre Close1.12MTurnover11.02%Turnover RatioLossP/E (Static)8.74MShares5.410052wk High1.37P/B10.93MFloat Cap1.001052wk Low--Dividend TTM7.75MShs Float51.5000Historical High--Div YieldTTM31.19%Amplitude1.0010Historical Low1.3100Avg Price1Lot Size
Alterity Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.33%142.66K | -51.39%176.84K |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -19.33%142.66K | -51.39%176.84K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 35.20%19.4M | -5.19%14.35M | 2.70%15.14M | 9.45%14.74M | 7.96%13.47M | 58.96%12.47M | 15.87%7.85M | -20.21%6.77M | -19.37%8.49M | -15.38%10.53M |
| Selling and administrative expenses | -6.33%4.62M | -9.57%4.94M | -20.44%5.46M | 105.85%6.86M | -22.09%3.33M | 2.00%4.28M | 6.27%4.19M | 10.02%3.95M | -19.82%3.59M | -8.74%4.47M |
| -General and administrative expense | -6.33%4.62M | -9.57%4.94M | -20.44%5.46M | 105.85%6.86M | -22.09%3.33M | 2.00%4.28M | 6.27%4.19M | 10.02%3.95M | -19.82%3.59M | -8.74%4.47M |
| Research and development costs | 41.26%18.64M | -10.49%13.2M | 20.04%14.75M | 21.64%12.28M | -22.22%10.1M | 93.84%12.98M | 17.50%6.7M | -40.53%5.7M | -22.06%9.59M | -17.51%12.3M |
| Depreciation amortization depletion | 44.26%147.53K | 88.63%102.26K | -28.07%54.21K | -32.96%75.37K | 278.59%112.43K | 36.23%29.7K | 2.21%21.8K | -6.50%21.33K | -27.79%22.81K | 41.11%31.59K |
| -Depreciation and amortization | 44.26%147.53K | 88.63%102.26K | -28.07%54.21K | -32.96%75.37K | 278.59%112.43K | 36.23%29.7K | 2.21%21.8K | -6.50%21.33K | -27.79%22.81K | 41.11%31.59K |
| Other taxes | -2.68%-4.02M | 16.17%-3.91M | -13.16%-4.67M | ---4.13M | --0 | -58.40%-4.95M | -3.41%-3.13M | 36.41%-3.02M | 21.93%-4.75M | 21.97%-6.09M |
| Other operating expenses | -80.81%5.24K | 106.03%27.3K | -27.01%-452.96K | -354.24%-356.63K | -159.05%-78.51K | 128.57%132.97K | -53.86%58.17K | 178.45%126.07K | 123.91%45.28K | -146.31%-189.33K |
| Operating profit | -35.20%-19.4M | 5.19%-14.35M | -2.70%-15.14M | -9.45%-14.74M | -7.96%-13.47M | -58.96%-12.47M | -15.87%-7.85M | 18.84%-6.77M | 19.37%-8.34M | 14.30%-10.35M |
| Net non-operating interest income expense | 1,533.12%268.42K | 556.39%16.44K | -87.89%2.5K | 20.79%20.68K | -84.23%17.12K | -46.05%108.54K | 51.95%201.17K | 132.4K | ||
| Non-operating interest income | 1,533.12%268.42K | 556.39%16.44K | -87.89%2.5K | 20.79%20.68K | -84.23%17.12K | -46.05%108.54K | 51.95%201.17K | --132.4K | ---- | ---- |
| Other net income (expense) | -91.30%56.52K | -72.44%649.73K | 498.72%2.36M | -7,432.00%-591.34K | -129.11%-7.85K | 105.44%26.97K | 45.08%-495.44K | -246.61%-902.11K | -86.22%615.29K | 464.82%4.46M |
| Gain on sale of security | -72.06%261.15K | -65.66%934.8K | 1,276.96%2.72M | -167.03%-231.31K | -1.14%345.07K | 228.87%349.06K | 58.97%-270.86K | -177.02%-660.21K | -81.84%857.25K | 732.40%4.72M |
| Other non- operating income (expenses) | 28.22%-204.63K | 21.83%-285.07K | -1.29%-364.67K | -2.01%-360.03K | -9.57%-352.92K | -43.42%-322.1K | 7.16%-224.58K | 0.03%-241.89K | 5.96%-241.95K | 46.07%-257.3K |
| Income before tax | -39.23%-19.08M | -7.24%-13.7M | 16.54%-12.78M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M |
| Income tax | -55.88%46.09K | 49.21%104.46K | 70.01K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -38.51%-19.12M | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M |
| Net income continuous Operations | -38.51%-19.12M | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -38.51%-19.12M | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -38.51%-19.12M | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M |
| Basic earnings per share | 8.77%-3.12 | -7.55%-3.42 | 41.11%-3.18 | 40.00%-5.4 | 25.00%-9 | -29.03%-12 | -9.93%-9.3 | 2.76%-8.46 | -23.93%-8.7 | 62.38%-7.02 |
| Diluted earnings per share | 8.77%-3.12 | -7.55%-3.42 | 41.11%-3.18 | 40.00%-5.4 | 25.00%-9 | -29.03%-12 | -9.93%-9.3 | 2.76%-8.46 | -23.93%-8.7 | 62.38%-7.02 |
| Dividend per share | ||||||||||
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
